StreetAlpha.app
Home › Stocks › ABT

Abbott Laboratories (ABT)

Healthcare
$104.76
▼ −2.50%
LAST CLOSE · NOV 17

Abbott makes pharmaceuticals, diagnostic tests, nutritional products, and medical devices for healthcare providers and consumers. It last closed at $104.76 on Nov 17, down 2.50% on the day. ABT reports earnings on Thu, Jan 28, 2027. The average 12-month price target from 9 analysts is $122.00 (+16.5% from the last close), with a high of $127.00 and a low of $118.00. Analyst consensus is Strong Buy, based on the latest ratings from 9 firms (9 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 5 whale options trades in ABT, 40% of them bullish and 60% bearish. In the past 30 days there were 19 dark pool prints totaling $31.4M, the largest $5.5M.

AI Auto Pilots
Is ABT in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$48.2B
+10.0% vs a year ago
Net income
$4.7B
−66.4% vs a year ago
EPS (diluted)
$2.69
−66.2% vs a year ago
Free cash flow
$6.8B
14.0% margin
Valuation
Market cap
$181B
1.73B shares
P/E
38.9
Price over 12 month EPS
Price to sales
3.8
Market cap over revenue
Dividend yield
2.41%
$2.52 a share over 12 months
Balance sheet
Cash & equivalents
$4.1B
At Sep 30
Debt
$31.2B
At Sep 30
Shareholder equity
$51.0B
Buybacks
$1.5B
Last 12 months
CEORobert Ford
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $43.1B$43.1BFY2021FY2022: $43.7B$43.7BFY2022FY2023: $40.1B$40.1BFY2023FY2024: $42.0B$42.0BFY2024FY2025: $44.3B$44.3BFY2025

From ABT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Jan 28
2027 · Time not announced
Consensus EPS forecast
$1.64
$13.21B revenue est.
Year-ago EPS
$1.50
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 9 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
9firms
9 Buy0 Hold0 Sell
Each firm's latest rating on ABT in the past 90 days
Average 12-month target
$122.00
▲ 16.5% upside

Based on 9 analysts who set a price target on ABT in the past 90 days. The average target is $122.00, with a high of $127.00 and a low of $118.00, compared with the last close of $104.76.

$82$98$114$130PAST 93 TRADING DAYS12-MONTH TARGETSHIGH $127AVG $122LOW $118May 22LAST CLOSE+12 MO$82$98$114$130PAST 93 DAYSTARGETSHIGH $127AVG $122LOW $118May 22LAST CLOSE+12 MO
Highest target$127.00
Average target$122.00
Lowest target$118.00
Latest rating changes
Wells FargoTarget raised
Oct 23Buy$119 → $120
CitigroupTarget raised
Oct 22Buy$112 → $122
RBC CapitalMaintained
Oct 22Buy$125
Wells FargoTarget raised
Oct 22Buy$112 → $119
JP MorganTarget lowered
Oct 22Buy$120 → $118
DateFirmActionRatingPrice target
Oct 23Wells FargoTarget raisedBuy$119 → $120
Oct 22CitigroupTarget raisedBuy$112 → $122
Oct 22RBC CapitalMaintainedBuy$125
Oct 22Wells FargoTarget raisedBuy$112 → $119
Oct 22JP MorganTarget loweredBuy$120 → $118
Loading…

Technical Analysis

ABT · as of the Nov 17 close · updated after every close
Moving sideways

The stock sits between its 20 and 50 day averages. It is 3% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 46). The nearest support is the 100 day average at $104.24, and the nearest resistance the Pivot at $105.84.

Short trendNeutral
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 2.9%/day
Key levels
$132.0352 week high+26.0%
$107.2520 day average+2.4%
$107.10Pivot R1+2.2%
$106.35Swing high (Oct 21)+1.5%
$105.84Pivot+1.0%
$104.76Last close
$104.24100 day average−0.5%
$103.8850 day average−0.8%
$103.50Pivot S1−1.2%
$102.89Swing low (Jul 31)−1.8%
$101.52200 day average−3.1%
$81.9752 week low−21.8%
Indicators
RSI (14)45.61Middle of its rangeNeutral
MACD1.14Below its signal lineBearish
Stochastic31.8Middle of its rangeNeutral
ADX (14)18.9No clear trend
Williams %R-87.5Oversold below −80, overbought above −20Oversold
CCI (20)-28.6Oversold below −100, overbought above 100Neutral
Rate of change−4.2%Change over 10 sessionsBearish
ATR (14)$3.00Typical daily range, 2.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for ABT

What happened before

See how ABT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bearish2 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow ABT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ABT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
5
Bullish
2
40%
Bearish
3
60%
Date span
Aug 24 – Oct 22
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
19
Notional
$31.4M
Largest print
$5.5M
Loading…

FLEX Options Activity

FLEX Flow →
Notable FLEX trades
None flagged
No unusually large, long-dated positions
Single-leg prints · 30D
6
$92K premium · + 4 multi-leg
Latest report
Nov 17

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily FLEX report for unusually large, long-dated positions. Multi-leg structures, such as paired calls and puts used for financing or hedging, are listed but not counted in these totals.

Loading…

ABT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●1,383 buying vs 1,265 selling
  • ▼Held by funds -1.7 pts
  • ▲Funds holding +37
  • ▼Superinvestors: 1 added, 4 cut
  • ▲Put/call 1.56 to 1.06
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding3,0232,986+1.2%
In funds' top 102722+22.7%
Held by funds78.4%80.1%−1.7 pts
New / increased211 / 1,172152 / 1,038+16.2%
Reduced / sold out1,140 / 1251,370 / 283−23.5%
Put/call ratio1.061.56−32.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ABT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ABT Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$1.5B
0.8% yield
Left in program
$5.6B
3.1% of value
Shares outstanding, 12 months
−0.4%
Fewer shares
Last quarter
$0
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
#130 of 358
 
Spent each quarter, last 3 yearsTop bar $1.0B
Dec 2023: $300.0M, average price $108.22Mar 2024: $0Jun 2024: $0Sep 2024: $750.0M, average price $107.05Dec 2024: $365.9M, average price $114.69Mar 2025: $0Jun 2025: $0Sep 2025: $302.5M, average price $124.76Dec 2025: $301.1M, average price $128.68Mar 2026: $0Jun 2026: $1.0B, average price $89.70Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABT is in one of them and how their past ABT trades turned out.

ABT in the AI portfolios
Loading…

ABT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ABT in an article yet. Here's the latest on the wider market.

ABT Congress Trades

All congress trades →
Trades, 12 months
58
Buys
24
41%
Sells
33
57%
People
17
Last filed Nov 9
Who traded ABT · since 2015
Latest 5 filings of 242
$15K – $50KTraded Oct 7, 2026Filed Nov 9, 2026
Thomas KeanSell (partial)
$1K – $15KTraded Sep 17, 2026Filed Oct 30, 2026
$50K – $100KTraded Oct 2, 2026Filed Oct 28, 2026
$1K – $15KTraded Sep 18, 2026Filed Oct 12, 2026
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$15K – $50KOct 7, 2026Nov 9, 202633 d
Thomas KeanR · NJSell (partial)$1K – $15KSep 17, 2026Oct 30, 202643 d
Pete SessionsR · TXSell$50K – $100KOct 2, 2026Oct 28, 202626 d
Gilbert CisnerosD · CABuy$1K – $15KSep 18, 2026Oct 12, 202624 d
Ro KhannaD · CABuy$1K – $15KSep 4, 2026Oct 7, 202633 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Abbott Laboratories

Abbott is a health care company based in Abbott Park, Illinois. It develops, makes, and sells products in four main areas: established pharmaceutical products, diagnostic systems and tests, nutritional products, and medical devices. Its customers include hospitals, clinics, laboratories, pharmacies, wholesalers, healthcare providers, government agencies, and consumers, and it sells in markets around the world.

Headquarters
Abbott Park, IL
Founded
1888